EquityZen Growth Technology Fund LLC - Series 1314
Raised
$251K
Investors
5
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1314 is a Delaware-domiciled pooled investment vehicle filed by EquityZen Advisors LLC on 2022-04-29, raising $251K from 5 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund has a $10K minimum investment and is part of EquityZen's platform of nearly 1,900 pre-IPO SPVs enabling secondary market access to private company equity.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pairing typical of private equity pooled funds with up to 99 beneficial owners. The $10K minimum represents the lower end of pre-IPO access vehicles, consistent with EquityZen's retail-accessible model for secondary shares in venture-backed companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.